Clinical Trial Update: A Study of Single Dose of LP-003 in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating a single dose of LP-003 in healthy adults. The trial status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Urticaria

Drugs mentioned

• LP-003

Snippet

Sponsor: Longbio Pharma | Conditions: Chronic Spontaneous Urticaria | Phase 1 | Status: ACTIVE_NOT_RECRUITING